HomeAI · summaries
Storia in 13 fonti
Patient Advocates Warn Trump Tariffs on Generic Drugs Could Drive Up Costs for Millions | Common Dreams
President Trump's plan to impose tariffs on imported generic drugs raises concerns among patient advocates.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
supplychaindive.com
Trump maps out 200% tariffs for generic pharmaceuticals
The president said Tuesday he would maintain duty-free treatment for qualifying goods the next two years before hiking the tariffs in ensuing years.
- ·
biopharmadive.com
Trump threatens tariffs on imported generic drugs
While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…
- ·
timesofindia.indiatimes.com
Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump on Tuesday announced a phased tariff regime on imported generic medicines, saying they will continue to enter the United States duty-free for two years…
- ·
economictimes.indiatimes.com
Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%
Trump has been pressuring drugmakers through his most-favored-nation drug pricing policy to lower prices to what people pay in other high-income countries.
- ·
cnbc.com
Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production
The phased schedule is intended to push generic drugmakers to move production onshore.
- ·
france24.com
Trump announces 100% tariffs on imported generic pharmaceutical drugs
US President Donald Trump announced a 100% tariff on imported generic pharmaceutical drugs on Tuesday. The tariff, which aims to bolster US pharmaceutical production, is set to go…
- ·
benzinga.com
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plan
Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.
- ·
newsbytesapp.com
Trump threatens tariff on generic medicines: Should India be worried?
US President Trump announced a two-year tariff exemption for imported generic medicines, warning of steep 200% duties if production doesn't shift to the US afterward.
- ·
swissinfo.ch
Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply
(Bloomberg) -- Generic drug manufacturers will have two years to move production to the US or face a 100% import duty from August 2028, President Donald Trump said, threatening…
- ·
hindustantimes.com
0, 100, 200: How Trump's latest generic medicines tariffs could affect India
Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year. | India News
- ·
Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm
Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufacturing and supply chain strategies. After…
- ·
Trump's 200% drug tariff plan: Is India's pharma industry about to face an economic storm?
The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one hundred percent, eventually reaching…
- ·
Trump’s 100% generic drug duty threatens US low-cost supply
President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028, rising to 200% a year later. The move…
- ·
200% Trump tariff shock? India’s cheap pills may still beat US rivals
US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical exporters, but the country's cost advantage…
- ·
Indian pharma firms may yet survive Trump's 200% tariff bombshell
Donald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say the long-term impact may be limited.…
- ·
Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
In a blow to India’s pharmaceutical industry, the Donald Trump administration has announced up to 200% tariffs on generic drugs that will be applicable in the coming years.
- ·
independent.co.uk
Trump announces plan for 200% tariffs on imported generic drugs
Under the plan, announced on Truth Social, generic drugs imported into the U.S. would remain tariff-free for two years beginning Aug. 1
- ·
eleconomista.es
Trump lleva su guerra comercial al mercado de los medicamentos genéricos y reaviva el temor de un alza de precios en EEUU
Donald Trump ha escalado de nuevo su ofensiva para reducir el precio de los medicamentos en Estados Unidos. Después de utilizar los aranceles como herramienta de presión sobre los…
- ·
statnews.com
Pharmalittle: We're reading about Trump's plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.
- ·
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.